RT @iofbonehealth: New paper: Characterizing patients initiating #abaloparatide, #teriparatide, or #denosumab in a real-world setting: US linked claims & EMR database analysis https://t.co/FjCMDY6rJM

-

from Twitter https://twitter.com/GastonR48222321

August 03, 2020 at 11:01AM

Comentarios

Publicar un comentario

Entradas más populares de este blog

RT @The_JBMR: Authors from @TwinsUKres suggest that Proton pump inhibitors use may influence total hip BMD, both directly and indirectly, via plasma metabolites involved in the sex hormone pathway @YasrabRaza @ruthcbowyer @kerrin_small @DrClaireSteves @MarioFalchi https://t.co/hHvSzCIv7y https://t.co/bHA8gNuGzZ

-
RT @The_JBMR: Authors from @TwinsUKres suggest that Proton pump inhibitors use may influence total hip BMD, both directly and indirectly, via plasma metabolites involved in the sex hormone pathway @YasrabRaza @ruthcbowyer @kerrin_small @DrClaireSteves @MarioFalchi https://t.co/hHvSzCIv7y https://t.co/bHA8gNuGzZ — Gaston Ramirez (@GastonR48222321) Dec 6, 2022 from Twitter https://twitter.com/GastonR48222321 December 06, 2022 at 11:03AM
Leer más

RT @iofbonehealth: IOF and ESCEO have announced that WCO-IOF-ESCEO 2022 has been transitioned to a fully virtual format, held from March 24-26, 2022. Including many ‘live’ virtual sessions with Q&A, the program will be available on-demand for 3 months post-congress. https://t.co/nBsqR4z9wz https://t.co/giROkJxixr

-
RT @iofbonehealth: IOF and ESCEO have announced that WCO-IOF-ESCEO 2022 has been transitioned to a fully virtual format, held from March 24-26, 2022. Including many ‘live’ virtual sessions with Q&A, the program will be available on-demand for 3 months post-congress. https://t.co/nBsqR4z9wz https://t.co/giROkJxixr — Gaston Ramirez (@GastonR48222321) Jan 14, 2022 from Twitter https://twitter.com/GastonR48222321 January 14, 2022 at 11:04AM
Leer más